Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore

MIST stock news

This page provides real-time market news, earnings updates, and company announcements related to Milestone Pharmaceuticals Inc. (MIST).

All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.

Last updated as of 2026-02-22 15:58 EST

Prothena Corporation plc announced that the company has the potential to receive up to $105 million in cumulative clinical milestone payments by the end of 2026. image

Prothena Corporation plc announced that the company has the potential to receive up to $105 million in cumulative clinical milestone payments by the end of 2026.

老虎证券2026-02-19 21:23:00
World's Largest Gold Miner Newmont Reports Q4 Earnings: Details image

World's Largest Gold Miner Newmont Reports Q4 Earnings: Details

Finviz2026-02-19 22:18:50
Piper Sandler Lowers Akebia Therapeutics (AKBA) PT to $4 as Firm Updates Estimates Following Year-End Reports image

Piper Sandler Lowers Akebia Therapeutics (AKBA) PT to $4 as Firm Updates Estimates Following Year-End Reports

Finviz2026-02-20 00:30:06
Abundia Global Impact Group Announces Pricing of $20 Million Registered Direct Offering of Common Stock image

Abundia Global Impact Group Announces Pricing of $20 Million Registered Direct Offering of Common Stock

Finviz2026-02-20 01:03:44
LMND Q4 Deep Dive: Accelerating Growth, Autonomous Car Insurance, and AI Investment Shape 2026 Outlook image

LMND Q4 Deep Dive: Accelerating Growth, Autonomous Car Insurance, and AI Investment Shape 2026 Outlook

Finviz2026-02-20 09:18:45
Fennec Pharmaceuticals Presents Real World Data Supporting the Integration and Clinical Use of PEDMARK in Treating Adults with Head & Neck Cancers image

Fennec Pharmaceuticals Presents Real World Data Supporting the Integration and Clinical Use of PEDMARK in Treating Adults with Head & Neck Cancers

Finviz2026-02-20 12:06:46
FDA Approval For AbbVie/AstraZeneca's Combination Treatment Could Set New Standard For Slow Growing Blood Cancer image

FDA Approval For AbbVie/AstraZeneca's Combination Treatment Could Set New Standard For Slow Growing Blood Cancer

Finviz2026-02-20 13:06:49
What's Going On With Garrett Motion Stock Friday? image

What's Going On With Garrett Motion Stock Friday?

Finviz2026-02-20 13:42:45
OKLO Business Model Explained: When Revenue Could Arrive image

OKLO Business Model Explained: When Revenue Could Arrive

Finviz2026-02-20 16:27:40
Li Auto Inc. (LI) Expands EV Reach with Supercharging Milestone image

Li Auto Inc. (LI) Expands EV Reach with Supercharging Milestone

Finviz2026-02-20 16:57:07
What's Going On With Starfighters Stock Today? image

What's Going On With Starfighters Stock Today?

Finviz2026-02-20 17:30:34
Morgan Stanley Adjusts Ashland Inc. (ASH) Model Following Fiscal Q1 Results image

Morgan Stanley Adjusts Ashland Inc. (ASH) Model Following Fiscal Q1 Results

Finviz2026-02-20 17:42:37
Nicolet Bankshares, Inc. (NIC) Completes its Merger with MidWestOne Financial Group image

Nicolet Bankshares, Inc. (NIC) Completes its Merger with MidWestOne Financial Group

Finviz2026-02-21 11:36:07
Alphabet (GOOG) Jumps 4% as Dividend Looms image

Alphabet (GOOG) Jumps 4% as Dividend Looms

Finviz2026-02-21 16:15:41
Why Savvy Investors Purchase During AI Stock Dips image

Why Savvy Investors Purchase During AI Stock Dips

101 finance2026-02-21 19:09:08
 Trump Says US Stock Market Could Double  image

Trump Says US Stock Market Could Double

Coinomedia2026-02-22 02:30:13
Oppenheimer Increased its Price Target on Amrize Ltd (AMRZ) to $70 and Maintains an Outperform Rating image

Oppenheimer Increased its Price Target on Amrize Ltd (AMRZ) to $70 and Maintains an Outperform Rating

Finviz2026-02-22 07:33:41
IREN (IREN) Added to MSCI USA Index, Boosting Exposure to Institutional Investors image

IREN (IREN) Added to MSCI USA Index, Boosting Exposure to Institutional Investors

Finviz2026-02-22 15:27:39
Mizuho Reiterates Outperform on Alphabet (GOOGL) With $410 Target Price image

Mizuho Reiterates Outperform on Alphabet (GOOGL) With $410 Target Price

Finviz2026-02-22 15:27:38
MoonLake Announces Positive Topline Results from its Phase 2 Clinical Trial of Sonelokimab in Axial Spondyloarthritis and Reports 2025 Financial Results image

MoonLake Announces Positive Topline Results from its Phase 2 Clinical Trial of Sonelokimab in Axial Spondyloarthritis and Reports 2025 Financial Results

Finviz2026-02-22 16:03:14

MIST stock chart

MIST stock details

MIST stock price change

On the last trading day, MIST stock closed at 1.70 USD, with a price change of -1.16% for the day.

Trade stock futures

About Bitget

The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more
MIST stock news